Education Posters Resources General Info Supporters

Registration Options

Activity Date: 04/19/2016

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

With the expected increase in PD as the population ages, knowledge of PD management will allow pharmacists to better optimize care. In recent years, advances in the basic and clinical sciences has yielded substantive new information which are relevant for the management of Parkinson disease. Management of Parkinson’s disease is becoming more complex. New information is available on biomarkers, motor and nonmotor symptoms, medications, management guidelines, and results of long-term studies for disease modification. Additionally, there is a need for continuing education on clinical aspects of PD that utilizes video aids to enhance learning.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity. (sign in first)
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

This course will be provided at the CPNP 2016 Annual Meeting, April 17-20, 2016. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Jack Chen, PharmD, BCPS, CGP, FASCP, FCCP

View biographical information and disclosures

Learning Objectives

  1. Identify the current hypotheses on the pathology and pathophysiology of Parkinson’s disease (PD).
  2. Describe the role and use of biomarkers in the screening and diagnosis of PD.
  3. Explain the efficacy and safety of new symptomatic drug therapies for the treatment of PD.
  4. Describe the results of recently completed trials for disease modification in PD.
  5. Discuss new developments in the management of non-motor symptoms of PD.

Continuing Education Credit and Disclosures

Activity Date: 04/19/2016
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-021-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-021-L01-P (1.0 contact hours).